by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials
Conditions: HIV Infections Interventions: Biological: HIV Therapeutic Biologic Mix – HIV GP120 plus HIV GP41 plus BCG Vaccine Mix for percutaneous use Sponsors: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair; UnitedHealthcare Active, not...
by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials
Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet recruiting Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet...
by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials
Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc. Completed Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc....
by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials
Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet recruiting Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet...
by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials
Conditions: Major Depression Interventions: Device: High-frequency repetitive transcranial magnetic stimulation; Device: Intermittent Theta Burst Stimulation Sponsors: Krajská zdravotní, a.s. – Nemocnice Most, o.z. Completed Conditions: Major Depression...
by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials
Conditions: Stroke; Balance; Validity and Safety Sponsors: Sanko University Completed Conditions: Stroke; Balance; Validity and Safety Sponsors: Sanko University Completed
